The University of Chicago Header Logo

Connection

Robert Rosenfield to Humans

Back to Details
This is a "connection" page, showing publications Robert Rosenfield has written about Humans.
Robert Rosenfield
Connection Strength
0.954
Humans
  1. Normal and Premature Adrenarche. Endocr Rev. 2021 11 16; 42(6):783-814.
    View in: PubMed
    Score: 0.027
  2. Current concepts of polycystic ovary syndrome pathogenesis. Curr Opin Pediatr. 2020 10; 32(5):698-706.
    View in: PubMed
    Score: 0.025
  3. Perspectives on the International Recommendations for the Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescence. J Pediatr Adolesc Gynecol. 2020 Oct; 33(5):445-447.
    View in: PubMed
    Score: 0.025
  4. Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 04 01; 103(4):1233-1257.
    View in: PubMed
    Score: 0.021
  5. Letter to the Editor: "Normal Pubertal Development in Daughters of Women With PCOS: A Controlled Study". J Clin Endocrinol Metab. 2017 07 01; 102(7):2560.
    View in: PubMed
    Score: 0.020
  6. The Effect of the Testis on the Ovary: Structure-Function Relationships in a Neonate with a Unilateral Ovotestis (Ovotesticular Disorder of Sex Development)?. Horm Res Paediatr. 2017; 87(3):205-212.
    View in: PubMed
    Score: 0.020
  7. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev. 2016 10; 37(5):467-520.
    View in: PubMed
    Score: 0.019
  8. The Diagnosis of Polycystic Ovary Syndrome in Adolescents. Pediatrics. 2015 Dec; 136(6):1154-65.
    View in: PubMed
    Score: 0.018
  9. Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype. J Clin Endocrinol Metab. 2015 Apr; 100(4):1234-6.
    View in: PubMed
    Score: 0.017
  10. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J Clin Endocrinol Metab. 2015 Apr; 100(4):1537-43.
    View in: PubMed
    Score: 0.017
  11. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum. J Pediatr Adolesc Gynecol. 2015 Dec; 28(6):412-9.
    View in: PubMed
    Score: 0.017
  12. Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013 Sep; 98(9):3572-83.
    View in: PubMed
    Score: 0.015
  13. Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2013 Apr; 98(4):1591-601.
    View in: PubMed
    Score: 0.015
  14. Comparison of detection of normal puberty in boys by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2012 Dec; 97(12):4596-604.
    View in: PubMed
    Score: 0.015
  15. Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril. 2012 Jul; 98(1):242-9.
    View in: PubMed
    Score: 0.014
  16. Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test. Hum Reprod. 2011 Nov; 26(11):3138-46.
    View in: PubMed
    Score: 0.014
  17. Normal pubertal development: part II: clinical aspects of puberty. Pediatr Rev. 2011 Jul; 32(7):281-92.
    View in: PubMed
    Score: 0.013
  18. Normal pubertal development: Part I: The endocrine basis of puberty. Pediatr Rev. 2011 Jun; 32(6):223-9.
    View in: PubMed
    Score: 0.013
  19. Assessing the value of treatments to increase height. N Engl J Med. 2011 Mar 31; 364(13):1274-6.
    View in: PubMed
    Score: 0.013
  20. Mutations of the hexose-6-phosphate dehydrogenase gene rarely cause hyperandrogenemic polycystic ovary syndrome. Steroids. 2011 Jan; 76(1-2):135-9.
    View in: PubMed
    Score: 0.013
  21. Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Res. 2010 Dec 10; 1364:186-97.
    View in: PubMed
    Score: 0.013
  22. Potential diagnostic utility of intermittent administration of short-acting gonadotropin-releasing hormone agonist in gonadotropin deficiency. Fertil Steril. 2010 Dec; 94(7):2697-702.
    View in: PubMed
    Score: 0.012
  23. Characterization of functionally typical and atypical types of polycystic ovary syndrome. J Clin Endocrinol Metab. 2009 May; 94(5):1587-94.
    View in: PubMed
    Score: 0.011
  24. Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab. 2009 May; 94(5):1579-86.
    View in: PubMed
    Score: 0.011
  25. Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index. J Clin Endocrinol Metab. 2009 Apr; 94(4):1168-75.
    View in: PubMed
    Score: 0.011
  26. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009 Jan; 123(1):84-8.
    View in: PubMed
    Score: 0.011
  27. What every physician should know about polycystic ovary syndrome. Dermatol Ther. 2008 Sep-Oct; 21(5):354-61.
    View in: PubMed
    Score: 0.011
  28. Perspectives on the endocrine society clinical practice guideline for the evaluation and treatment of women with hirsutism. Endokrynol Pol. 2008 May-Jun; 59(3):254-5.
    View in: PubMed
    Score: 0.011
  29. Improving balance in regulatory oversight of research in children and adolescents: a clinical investigator's perspective. Ann N Y Acad Sci. 2008; 1135:287-95.
    View in: PubMed
    Score: 0.010
  30. Does a primary acceleration of LH pulse frequency underlie an association between central precocious puberty and polycystic ovary syndrome? Commentary on Escobar ME et al: Acceleration of LH pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism (Horm Res 2007;68:278-285). Horm Res. 2007; 68(6):286-7.
    View in: PubMed
    Score: 0.010
  31. Sexual hormones in human skin. Horm Metab Res. 2007 Feb; 39(2):85-95.
    View in: PubMed
    Score: 0.010
  32. Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2007 Jan; 20(1):41-51.
    View in: PubMed
    Score: 0.010
  33. Clinical review: Identifying children at risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Mar; 92(3):787-96.
    View in: PubMed
    Score: 0.010
  34. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome. J Clin Endocrinol Metab. 2006 Apr; 91(4):1275-83.
    View in: PubMed
    Score: 0.009
  35. A workshop on pubertal hormone replacement options in the United States. J Pediatr Endocrinol Metab. 2006 Jan; 19(1):55-64.
    View in: PubMed
    Score: 0.009
  36. Clinical practice. Hirsutism. N Engl J Med. 2005 Dec 15; 353(24):2578-88.
    View in: PubMed
    Score: 0.009
  37. Hirsutism and the variable response of the pilosebaceous unit to androgen. J Investig Dermatol Symp Proc. 2005 Dec; 10(3):205-8.
    View in: PubMed
    Score: 0.009
  38. Identification of a functional polymorphism of the human type 5 17beta-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006 Jan; 91(1):270-6.
    View in: PubMed
    Score: 0.009
  39. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. J Clin Endocrinol Metab. 2005 Dec; 90(12):6424-30.
    View in: PubMed
    Score: 0.009
  40. Polycystic ovary syndrome in adolescence. Endocrinol Metab Clin North Am. 2005 Sep; 34(3):677-705, x.
    View in: PubMed
    Score: 0.009
  41. Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene. Biochim Biophys Acta. 2005 May 01; 1728(3):115-25.
    View in: PubMed
    Score: 0.009
  42. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. J Clin Endocrinol Metab. 2003 Dec; 88(12):6115; author reply 6115-6.
    View in: PubMed
    Score: 0.008
  43. Bartter syndrome complicated by immune complex nephropathy. Case report and literature review. Pediatr Nephrol. 2003 Sep; 18(9):913-8.
    View in: PubMed
    Score: 0.008
  44. Molecular genetic and endocrine mechanisms of hair growth. Horm Res. 2003; 60(1):1-13.
    View in: PubMed
    Score: 0.007
  45. Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2002 Jun; 87(6):2993; author reply 2993.
    View in: PubMed
    Score: 0.007
  46. Oestrogens and puberty. Best Pract Res Clin Endocrinol Metab. 2002 Mar; 16(1):13-30.
    View in: PubMed
    Score: 0.007
  47. Polycystic ovary syndrome and insulin-resistant hyperinsulinemia. J Am Acad Dermatol. 2001 Sep; 45(3 Suppl):S95-104.
    View in: PubMed
    Score: 0.007
  48. Current age of onset of puberty. Pediatrics. 2000 Sep; 106(3):622-3.
    View in: PubMed
    Score: 0.006
  49. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000 Aug; 21(4):363-92.
    View in: PubMed
    Score: 0.006
  50. Hyperhidrosis as the only manifestation of hyperandrogenism in an adolescent girl. Arch Dermatol. 2000 Mar; 136(3):430-1.
    View in: PubMed
    Score: 0.006
  51. Expression of 17 beta-hydroxysteroid dehydrogenase type 5 in human ovary: a pilot study. J Soc Gynecol Investig. 2000 Jan-Feb; 7(1):61-4.
    View in: PubMed
    Score: 0.006
  52. Optimizing estrogen replacement in adolescents with Turner syndrome. Ann N Y Acad Sci. 2000; 900:213-4.
    View in: PubMed
    Score: 0.006
  53. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1285-9.
    View in: PubMed
    Score: 0.006
  54. Peroxisome proliferator-activated receptors and skin development. Horm Res. 2000; 54(5-6):269-74.
    View in: PubMed
    Score: 0.006
  55. Intrauterine growth retardation associated with maternal uniparental disomy for chromosome 6 unmasked by congenital adrenal hyperplasia. Pediatr Res. 1999 Nov; 46(5):510-3.
    View in: PubMed
    Score: 0.006
  56. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology. 1999 Sep; 140(9):4089-94.
    View in: PubMed
    Score: 0.006
  57. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999 Jun; 28(2):265-93.
    View in: PubMed
    Score: 0.006
  58. Role of cytochrome P450c17 in polycystic ovary syndrome. Mol Cell Endocrinol. 1998 Oct 25; 145(1-2):111-21.
    View in: PubMed
    Score: 0.006
  59. Optimizing estrogen replacement treatment in Turner syndrome. Pediatrics. 1998 Aug; 102(2 Pt 3):486-8.
    View in: PubMed
    Score: 0.005
  60. Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations. J Clin Endocrinol Metab. 2018 05 01; 103(5):1790-1803.
    View in: PubMed
    Score: 0.005
  61. Is polycystic ovary syndrome a neuroendocrine or an ovarian disorder? Clin Endocrinol (Oxf). 1997 Oct; 47(4):423-4.
    View in: PubMed
    Score: 0.005
  62. A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism. Hum Reprod. 1997 Jul; 12(7):1416-20.
    View in: PubMed
    Score: 0.005
  63. Current concepts of polycystic ovary syndrome. Baillieres Clin Obstet Gynaecol. 1997 Jun; 11(2):307-33.
    View in: PubMed
    Score: 0.005
  64. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor--a clinical research center study. J Clin Endocrinol Metab. 1996 Oct; 81(10):3802-6.
    View in: PubMed
    Score: 0.005
  65. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study. J Clin Endocrinol Metab. 1996 Sep; 81(9):3408-11.
    View in: PubMed
    Score: 0.005
  66. Essentials of growth diagnosis. Endocrinol Metab Clin North Am. 1996 Sep; 25(3):743-58.
    View in: PubMed
    Score: 0.005
  67. Physician and clinic charges for diagnosing growth hormone deficiency. J Pediatr. 1996 May; 128(5 Pt 2):S61-2.
    View in: PubMed
    Score: 0.005
  68. Evidence that idiopathic functional adrenal hyperandrogenism is caused by dysregulation of adrenal steroidogenesis and that hyperinsulinemia may be involved. J Clin Endocrinol Metab. 1996 Mar; 81(3):878-80.
    View in: PubMed
    Score: 0.005
  69. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study. J Clin Endocrinol Metab. 1995 Oct; 80(10):2980-6.
    View in: PubMed
    Score: 0.004
  70. Are adrenal and ovarian function normal in true precocious puberty? Eur J Endocrinol. 1995 Oct; 133(4):399-400.
    View in: PubMed
    Score: 0.004
  71. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 1995 Jun; 16(3):322-53.
    View in: PubMed
    Score: 0.004
  72. Role of androgens in the developmental biology of the pilosebaceous unit. Am J Med. 1995 Jan 16; 98(1A):80S-88S.
    View in: PubMed
    Score: 0.004
  73. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
    View in: PubMed
    Score: 0.004
  74. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. J Clin Endocrinol Metab. 1994 Jun; 78(6):1336-40.
    View in: PubMed
    Score: 0.004
  75. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr. 1994 Jun; 124(6):989-91.
    View in: PubMed
    Score: 0.004
  76. Normal and almost normal precocious variations in pubertal development premature pubarche and premature thelarche revisited. Horm Res. 1994; 41 Suppl 2:7-13.
    View in: PubMed
    Score: 0.004
  77. Menstrual disorders in adolescence. Endocrinol Metab Clin North Am. 1993 Sep; 22(3):491-505.
    View in: PubMed
    Score: 0.004
  78. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess. Endocrinol Metab Clin North Am. 1993 Sep; 22(3):507-32.
    View in: PubMed
    Score: 0.004
  79. Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girls. Clin Obstet Gynecol. 1993 Sep; 36(3):773-85.
    View in: PubMed
    Score: 0.004
  80. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann N Y Acad Sci. 1993 May 28; 687:162-81.
    View in: PubMed
    Score: 0.004
  81. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1993 Feb; 76(2):450-5.
    View in: PubMed
    Score: 0.004
  82. Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid. J Clin Endocrinol Metab. 1992 May; 74(5):1036-9.
    View in: PubMed
    Score: 0.004
  83. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone. J Pediatr. 1992 May; 120(5):709-15.
    View in: PubMed
    Score: 0.004
  84. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab. 2012 Jul; 97(7):E1342-7.
    View in: PubMed
    Score: 0.004
  85. Is an immunoassay available for the measurement of bioactive LH in serum? J Androl. 1992 Jan-Feb; 13(1):1-10.
    View in: PubMed
    Score: 0.003
  86. P450c17 deficiency caused by compound heterozygosity for two novel mutations presenting as hypotension in early infancy. Horm Res Paediatr. 2011; 76(6):434-41.
    View in: PubMed
    Score: 0.003
  87. Puberty and its disorders in girls. Endocrinol Metab Clin North Am. 1991 Mar; 20(1):15-42.
    View in: PubMed
    Score: 0.003
  88. Hyperandrogenism in peripubertal girls. Pediatr Clin North Am. 1990 Dec; 37(6):1333-58.
    View in: PubMed
    Score: 0.003
  89. Hirsutism--beyond the steroidogenic block. N Engl J Med. 1990 Sep 27; 323(13):909-11.
    View in: PubMed
    Score: 0.003
  90. Clinical review 10: An endocrinologic approach to the patient with hirsutism. J Clin Endocrinol Metab. 1990 Jul; 71(1):1-4.
    View in: PubMed
    Score: 0.003
  91. Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril. 1990 May; 53(5):785-91.
    View in: PubMed
    Score: 0.003
  92. Clinical review 6: Diagnosis and management of delayed puberty. J Clin Endocrinol Metab. 1990 Mar; 70(3):559-62.
    View in: PubMed
    Score: 0.003
  93. Use of nafarelin for testing pituitary-ovarian function. J Reprod Med. 1989 Dec; 34(12 Suppl):1044-50.
    View in: PubMed
    Score: 0.003
  94. Growth hormone deficiency impedes the rise in plasma insulin-like growth factor I levels associated with precocious puberty. J Pediatr. 1989 Jul; 115(1):64-8.
    View in: PubMed
    Score: 0.003
  95. KLF15 Is a transcriptional regulator of the human 17beta-hydroxysteroid dehydrogenase type 5 gene. A potential link between regulation of testosterone production and fat stores in women. J Clin Endocrinol Metab. 2009 Jul; 94(7):2594-601.
    View in: PubMed
    Score: 0.003
  96. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr; 123(4):e752-62.
    View in: PubMed
    Score: 0.003
  97. The polycystic ovary syndrome: pathogenesis and treatment. Ann Intern Med. 1989 Mar 01; 110(5):386-99.
    View in: PubMed
    Score: 0.003
  98. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 1988 Aug; 123(2):733-9.
    View in: PubMed
    Score: 0.003
  99. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008 Apr; 93(4):1105-20.
    View in: PubMed
    Score: 0.003
  100. Paternal deletion 6q24.3: a new congenital anomaly syndrome associated with intrauterine growth failure, early developmental delay and characteristic facial appearance. Am J Med Genet A. 2008 Feb 01; 146A(3):354-60.
    View in: PubMed
    Score: 0.003
  101. Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report. J Reprod Med. 1987 May; 32(5):363-9.
    View in: PubMed
    Score: 0.002
  102. The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol. 1987 Feb; 123(2):209-12.
    View in: PubMed
    Score: 0.002
  103. KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans. Mol Hum Reprod. 2007 Mar; 13(3):165-70.
    View in: PubMed
    Score: 0.002
  104. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity. J Clin Endocrinol Metab. 1986 Dec; 63(6):1386-9.
    View in: PubMed
    Score: 0.002
  105. Estradiol inhibition of pituitary luteinizing hormone release is antagonized by serum proteins. J Steroid Biochem. 1986 Sep; 25(3):309-14.
    View in: PubMed
    Score: 0.002
  106. Pubertal data for growth velocity charts. J Pediatr. 1986 Sep; 109(3):564-5.
    View in: PubMed
    Score: 0.002
  107. Functional significance of polycystic-size ovaries in healthy adolescents. J Clin Endocrinol Metab. 2006 Oct; 91(10):3786-90.
    View in: PubMed
    Score: 0.002
  108. Low-dose testosterone effect on somatic growth. Pediatrics. 1986 Jun; 77(6):853-7.
    View in: PubMed
    Score: 0.002
  109. Pilosebaceous physiology in relation to hirsutism and acne. Clin Endocrinol Metab. 1986 May; 15(2):341-62.
    View in: PubMed
    Score: 0.002
  110. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab. 1985 Sep; 61(3):508-13.
    View in: PubMed
    Score: 0.002
  111. Physiologic testosterone or estradiol induction of puberty increases plasma somatomedin-C. J Pediatr. 1985 Sep; 107(3):415-7.
    View in: PubMed
    Score: 0.002
  112. Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin. J Clin Endocrinol Metab. 1985 Mar; 60(3):585-9.
    View in: PubMed
    Score: 0.002
  113. GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A. Hum Reprod. 2004 Dec; 19(12):2748-58.
    View in: PubMed
    Score: 0.002
  114. Advances in diagnosis and treatment of short stature, with special reference to the role of growth hormone. J Pediatr. 1984 Jun; 104(6):801-13.
    View in: PubMed
    Score: 0.002
  115. Androgen metabolism by isolated hairs from women with idiopathic hirsutism is usually normal. J Invest Dermatol. 1984 Jan; 82(1):62-6.
    View in: PubMed
    Score: 0.002
  116. Puberty in girls born to infertile women after gonadotropin therapy. JAMA. 1983 Dec 16; 250(23):3201.
    View in: PubMed
    Score: 0.002
  117. Toward optimal estrogen-replacement therapy. N Engl J Med. 1983 Nov 03; 309(18):1120-1.
    View in: PubMed
    Score: 0.002
  118. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr. 1983 Mar; 102(3):461-4.
    View in: PubMed
    Score: 0.002
  119. Evaluation of women with hirsutism. Compr Ther. 1983 Feb; 9(2):25-32.
    View in: PubMed
    Score: 0.002
  120. Adrenarche as a cause of benign pseudopuberty in boys. J Pediatr. 1982 Dec; 101(6):1005-9.
    View in: PubMed
    Score: 0.002
  121. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002 Jan; 17(1):88-91.
    View in: PubMed
    Score: 0.002
  122. Induction of puberty in the hypogonadal girl--practices and attitudes of pediatric endocrinologists in Europe. Horm Res. 2002; 57(1-2):66-71.
    View in: PubMed
    Score: 0.002
  123. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001 Dec; 86(12):5925-33.
    View in: PubMed
    Score: 0.002
  124. Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency. N Engl J Med. 2000 Oct 19; 343(16):1197-8.
    View in: PubMed
    Score: 0.002
  125. Pubertal presentation of congenital delta 5-3 beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1980 Aug; 51(2):345-53.
    View in: PubMed
    Score: 0.002
  126. Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet Gynecol. 1980 Aug; 56(2):208-15.
    View in: PubMed
    Score: 0.002
  127. Testosterone binding and free plasma androgen concentrations under physiological conditons: chararacterization by flow dialysis technique. J Clin Endocrinol Metab. 1979 Nov; 49(5):730-6.
    View in: PubMed
    Score: 0.001
  128. Gonadotropin-releasing hormone infusion test in the distinction of hypopituitary patients from normal subjects. Fertil Steril. 1979 May; 31(5):507-12.
    View in: PubMed
    Score: 0.001
  129. Plasma free androgen patterns in hirsute women and their diagnostic implications. Am J Med. 1979 Mar; 66(3):417-21.
    View in: PubMed
    Score: 0.001
  130. Significance of genetic testing for paternal uniparental disomy of chromosome 6 in neonatal diabetes mellitus. J Pediatr. 1999 Jan; 134(1):42-6.
    View in: PubMed
    Score: 0.001
  131. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999 Jan; 22(1):141-6.
    View in: PubMed
    Score: 0.001
  132. Direct inhibition of Leydig cell function by estradiol. J Clin Endocrinol Metab. 1978 Dec; 47(6):1368-73.
    View in: PubMed
    Score: 0.001
  133. Some limitations of using equilibrium dialysis to study human serum albumin-testosterone interaction. J Clin Endocrinol Metab. 1978 Mar; 46(3):501-3.
    View in: PubMed
    Score: 0.001
  134. DES effect on males. Pediatrics. 1978 Jan; 61(1):154-5.
    View in: PubMed
    Score: 0.001
  135. Oxandrolone therapy for children with Turner syndrome. J Pediatr. 1977 Nov; 91(5):854-6.
    View in: PubMed
    Score: 0.001
  136. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997 Jul; 82(7):2108-16.
    View in: PubMed
    Score: 0.001
  137. Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature. J Pediatr. 1997 Jul; 131(1 Pt 2):S51-5.
    View in: PubMed
    Score: 0.001
  138. The relationship between plasma testosterone and mean LH levels in men. J Clin Endocrinol Metab. 1977 Jul; 45(1):30-4.
    View in: PubMed
    Score: 0.001
  139. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997 Feb; 82(2):524-30.
    View in: PubMed
    Score: 0.001
  140. The effects of fluoxymesterone administration on testicular function. J Clin Endocrinol Metab. 1977 Jan; 44(1):121-9.
    View in: PubMed
    Score: 0.001
  141. Obesity and oligomenorrhea are associated with hyperandrogenism independent of hirsutism. J Clin Endocrinol Metab. 1976 Apr; 42(4):765-9.
    View in: PubMed
    Score: 0.001
  142. Linkage of congenital isolated adrenocorticotropic hormone deficiency to the corticotropin releasing hormone locus using simple sequence repeat polymorphisms. Am J Med Genet. 1996 Mar 29; 62(3):262-7.
    View in: PubMed
    Score: 0.001
  143. Plasma unbound and unconjugated androgens in oriental men. J Endocrinol. 1976 Jan; 68(1):165-6.
    View in: PubMed
    Score: 0.001
  144. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest. 1995 Jul; 96(1):520-7.
    View in: PubMed
    Score: 0.001
  145. Studies of the relation of plasma androgen levels to androgen action in women. J Steroid Biochem. 1975 May; 6(5):695-702.
    View in: PubMed
    Score: 0.001
  146. Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia. J Clin Invest. 1975 Apr; 55(4):681-90.
    View in: PubMed
    Score: 0.001
  147. Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study. Lab Invest. 1974 Dec; 31(6):648-57.
    View in: PubMed
    Score: 0.001
  148. The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agers. J Pediatr. 1974 Dec; 85(6):830-7.
    View in: PubMed
    Score: 0.001
  149. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994 Nov; 79(5):1328-33.
    View in: PubMed
    Score: 0.001
  150. Neonatal hypothyroidism and goiter in one infant of each of two sets of twins due to maternal therapy with antithyroid drugs. J Pediatr. 1974 Aug; 85(2):240-4.
    View in: PubMed
    Score: 0.001
  151. The response to human chorionic gonadotropin (HCG) administration in boys with and without delta5-3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1974 Aug; 39(2):370-4.
    View in: PubMed
    Score: 0.001
  152. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency. J Clin Endocrinol Metab. 1994 Mar; 78(3):561-7.
    View in: PubMed
    Score: 0.001
  153. The effects of low doses of depot estradiol and testosterone in teenagers with ovarian failure and Turner's syndrome. J Clin Endocrinol Metab. 1973 Oct; 37(4):574-80.
    View in: PubMed
    Score: 0.001
  154. Relationship of androgens to female hirsutism and infertility. J Reprod Med. 1973 Sep; 11(3):87-95.
    View in: PubMed
    Score: 0.001
  155. Defects in beta-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993 May; 76(5):1241-7.
    View in: PubMed
    Score: 0.001
  156. Maturation of gonadotropin and sex steroid responses to gonadotropin-releasing hormone agonist in males. J Clin Endocrinol Metab. 1993 Feb; 76(2):362-6.
    View in: PubMed
    Score: 0.001
  157. Androstenediol levels in human peripheral plasma. J Clin Endocrinol Metab. 1972 Dec; 35(6):818-22.
    View in: PubMed
    Score: 0.001
  158. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
    View in: PubMed
    Score: 0.001
  159. Managing delayed puberty. Postgrad Med. 1972 May; 51(5):204-9.
    View in: PubMed
    Score: 0.001
  160. Isosexual pseudoprecocity in a 6-year-old boy with a testicular interstitial cell adenoma. J Pediatr. 1972 Feb; 80(2):264-8.
    View in: PubMed
    Score: 0.001
  161. Adrenal and ovarian contributions to the elevated free plasma androgen levels in hirsute women. J Clin Endocrinol Metab. 1972 Jan; 34(1):92-8.
    View in: PubMed
    Score: 0.001
  162. Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics. Mol Endocrinol. 1991 Oct; 5(10):1562-9.
    View in: PubMed
    Score: 0.001
  163. Plasma 17-ketosteroids and 17-beta hydroxysteroids in girls with premature development of sexual hair. J Pediatr. 1971 Aug; 79(2):260-6.
    View in: PubMed
    Score: 0.001
  164. Plasma 17-ketosteroids and testosterone in prepubertal children before and after ACTH administration. J Clin Endocrinol Metab. 1971 Aug; 33(2):249-53.
    View in: PubMed
    Score: 0.001
  165. A competitive protein binding method for the measurement of unconjugated and sulfate-conjugated dehydroepiandrosterone in peripheral plasma. Steroids. 1971 Jun; 17(6):689-96.
    View in: PubMed
    Score: 0.001
  166. Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. J Clin Endocrinol Metab. 1971 Jun; 32(6):717-28.
    View in: PubMed
    Score: 0.001
  167. Androgens and androgen responsiveness in the feminizing testis syndrome. Comparison of complete and "incomplete" forms. J Clin Endocrinol Metab. 1971 May; 32(5):625-32.
    View in: PubMed
    Score: 0.001
  168. Serum testosterone as an index of gonadotrophin secretion in acromegaly and pituitary disease. Acta Endocrinol (Copenh). 1970 Oct; 65(2):302-8.
    View in: PubMed
    Score: 0.001
  169. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr. 1990 Sep; 117(3):364-70.
    View in: PubMed
    Score: 0.001
  170. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies. J Clin Endocrinol Metab. 1989 Nov; 69(5):963-7.
    View in: PubMed
    Score: 0.001
  171. A competitive protein binding method for the measurement of plasma androstenedione. Steroids. 1969 Sep; 14(3):251-61.
    View in: PubMed
    Score: 0.001
  172. Plasma 17-ketosteroid levels during adolescence. J Pediatr. 1969 Jun; 74(6):932-6.
    View in: PubMed
    Score: 0.001
  173. Measurement of plasma testosterone by means of competitive protein binding analysis. J Clin Endocrinol Metab. 1969 Jun; 29(6):854-9.
    View in: PubMed
    Score: 0.001
  174. Plasma testosterone and dehydroepiandrosterone sulfate during puberty. J Pediatr. 1969 May; 74(5):830-1.
    View in: PubMed
    Score: 0.001
  175. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
    View in: PubMed
    Score: 0.001
  176. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone. Clin Endocrinol (Oxf). 1988 May; 28(5):471-7.
    View in: PubMed
    Score: 0.001
  177. Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration. J Clin Endocrinol Metab. 1988 Apr; 66(4):740-6.
    View in: PubMed
    Score: 0.001
  178. A longitudinal study of the relationship of plasma somatomedin-C concentration to the pubertal growth spurt. Am J Dis Child. 1987 May; 141(5):562-4.
    View in: PubMed
    Score: 0.001
  179. Idiopathic anterior hypopituitarism in one of monozygous twins. J Pediatr. 1967 Jan; 70(1):115-7.
    View in: PubMed
    Score: 0.001
  180. Studies of androgen metabolism and action in cultured hair and skin cells. J Steroid Biochem. 1986 May; 24(5):1053-60.
    View in: PubMed
    Score: 0.001
  181. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. J Clin Endocrinol Metab. 1986 May; 62(5):840-8.
    View in: PubMed
    Score: 0.001
  182. Administration of low-dose estrogen rapidly and directly stimulates growth hormone production. Am J Dis Child. 1986 Feb; 140(2):124-7.
    View in: PubMed
    Score: 0.001
  183. Plasma androgens in women with acne vulgaris. J Invest Dermatol. 1983 Jul; 81(1):70-4.
    View in: PubMed
    Score: 0.000
  184. Multiple androgenic abnormalities, including elevated free testosterone, in hyperprolactinemic women. J Clin Endocrinol Metab. 1982 Aug; 55(2):251-7.
    View in: PubMed
    Score: 0.000
  185. Bioactive luteinizing hormone pituitary reserves during normal and abnormal male puberty. J Clin Endocrinol Metab. 1982 Jul; 55(1):140-6.
    View in: PubMed
    Score: 0.000
  186. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981 Aug 01; 140(7):815-30.
    View in: PubMed
    Score: 0.000
  187. Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab. 1981 Jun; 52(6):1129-36.
    View in: PubMed
    Score: 0.000
  188. Estradiol-testosterone binding interactions and free plasma estradiol under physiological conditions. J Clin Endocrinol Metab. 1981 May; 52(5):868-74.
    View in: PubMed
    Score: 0.000
  189. LH bioactivity increases more than immunoreactivity during puberty. J Pediatr. 1980 Aug; 97(2):205-13.
    View in: PubMed
    Score: 0.000
  190. Bioactive LH: a test to discriminate true precocious puberty from premature thelarche and adrenarche. J Pediatr. 1980 Aug; 97(2):214-6.
    View in: PubMed
    Score: 0.000
  191. Parameters of response to clompiphene citrate in oligospermic men. J Urol. 1980 Jul; 124(1):53-5.
    View in: PubMed
    Score: 0.000
  192. Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries. Am J Obstet Gynecol. 1979 Jun 15; 134(4):445-52.
    View in: PubMed
    Score: 0.000
  193. Reduction of the potency of luteinizing hormone by estrogen. N Engl J Med. 1979 May 03; 300(18):1034-6.
    View in: PubMed
    Score: 0.000
  194. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh). 1978 Jun; 88(2):321-8.
    View in: PubMed
    Score: 0.000
  195. Endocrine and metabolic studies in a patient with male pseudohermaphroditism and true agonadism. Am J Obstet Gynecol. 1977 Aug 15; 128(8):862-7.
    View in: PubMed
    Score: 0.000
  196. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol. 1977 Jan; 49(1):1-8.
    View in: PubMed
    Score: 0.000
  197. The effects of dexamethasone on plasma free androgens during the normal menstrual cycle. Am J Obstet Gynecol. 1976 Dec 15; 126(8):982-6.
    View in: PubMed
    Score: 0.000
  198. Growth retardation and zinc nutrition. Pediatr Res. 1976 Nov; 10(11):923-7.
    View in: PubMed
    Score: 0.000
  199. Endocrinologic characteristics of partial ovarian failure. J Clin Endocrinol Metab. 1976 Aug; 43(2):449-52.
    View in: PubMed
    Score: 0.000
  200. The levodopa test of growth hormone reserve in children. Am J Dis Child. 1973 Nov; 126(5):589-92.
    View in: PubMed
    Score: 0.000
  201. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity. N Engl J Med. 1973 May 31; 288(22):1144-8.
    View in: PubMed
    Score: 0.000
  202. Familial glucocorticoid insufficiency. J Pediatr. 1973 May; 82(5):821-6.
    View in: PubMed
    Score: 0.000
  203. Sequential changes in total and free testosterone and androstenedione in plasma during spontaneous and Clomid-induced ovulatory cycles. Am J Obstet Gynecol. 1973 Feb 15; 115(4):478-83.
    View in: PubMed
    Score: 0.000
  204. Hyperleydigism: a cause of severe pubertal gynecomastia. J Clin Endocrinol Metab. 1971 Jun; 32(6):751-6.
    View in: PubMed
    Score: 0.000
  205. The measurement of urinary testosterone glucuronide by competitive protein binding and validation by a double isotope derivative assay. Steroids. 1969 Feb; 13(2):227-45.
    View in: PubMed
    Score: 0.000
  206. The plasma growth hormone response to insulin-induced hypoglycemia in children with retardation of growth. Pediatrics. 1967 Jun; 39(6):844-52.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.